Log In
Print this Print this

Abasria (LY2963016)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionBasal insulin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationDiabetes
Indication DetailsTreat Type I and II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

U.S. - Undisclosed Review (Treat Type I and II diabetes);
EU - Standard Review (Treat Type I and II diabetes)


Boehringer Ingelheim GmbH

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today